查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1984177

NGS試劑盒市場：2026-2032年全球市場預測（按產品類型、定序技術、樣本類型、應用和最終用戶分類）

NGS Kits Market by Product Type, Sequencing Technology, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

NGS試劑盒市場預計到2025年將達到28.2億美元，到2026年將成長到31.7億美元，到2032年將達到66.5億美元，複合年成長率為13.03%。

主要市場統計數據
基準年 2025 28.2億美元
預計年份：2026年 31.7億美元
預測年份 2032 66.5億美元
複合年成長率 (%) 13.03%

對定序盒在研究和臨床環境中實現穩健的基因組和轉錄組分析工作流程方面不斷演變的作用進行了權威說明。

次世代定序盒是基礎工具，可在科研、臨床和工業領域實現高解析度的基因組、轉錄組和表觀基因分析。這些試劑盒包含試劑、耗材和樣品製備流程，用於將生物樣品轉化為定序的文庫和模板，其性能特徵顯著影響下游數據的品質和可解釋性。隨著定序應用的日益多樣化，試劑盒設計也在不斷發展，優先考慮柔軟性、通量適應性和最大限度減少人工干預，從而支持更廣泛的實驗設計，從靶向測序到全基因組分析。

化學、自動化和平台相容性的創新整合正在重新定義定序盒，並改變整個基因組學領域的實驗工作流程。

定序盒領域正經歷一場變革，這得益於化學定序、奈米孔定序和合成定序等讀取技術的平行發展，以及單細胞定序和長讀長定序應用的日趨成熟。傳統的定序流程著重於逐步提高讀取準確性和通量，而近期的進展已將重點轉向通用性和端到端流程最佳化。例如，樣品製備變得更加模組化，使得實驗室能夠在不大幅改變通訊協定的情況下調整起始樣本量和富集策略。同時，模板製備和基於PCR的擴增技術的改進提高了定序結果的均一性並降低了偏差，尤其是在複雜基因組和低起始樣本的情況下。

評估近期關稅變化對營運和供應鏈的影響，以及對定序盒採購韌性和供應商策略的影響。

貿易政策的變化，包括關稅調整，正對定序盒的採購和分銷產生切實的影響，尤其對於那些跨境採購試劑、耗材和儀器兼容配件的企業而言更是如此。關稅正在改變最終成本，促使企業重新評估其供應商組合，採用替代物流策略，或將部分生產活動在地化，以維持可靠的供應和可預測的獎勵。因此，採購團隊和銷售經理正在審查與供應商的契約，並探索降低成本大幅上漲風險的合約機制。同時，監管和海關合規部門也在加強文件流程，以避免運輸延誤。

將產品類型、應用需求、最終用戶畫像和定序技術與策略性試劑盒設計和部署聯繫起來的全面細分洞察。

詳細的細分闡明了構成定序試劑盒生態系統的各個產品配置和使用者需求。產品類型分為樣品製備盒、定序試劑盒和模板建構試劑盒。樣品製備盒進一步細分為擴增子特異性試劑盒、RNA定序最佳化試劑盒和全基因組文庫解決方案。定序試劑盒類型包括邊合成邊定序（SBS）配方以及奈米孔導向的化學系統，其中奈米孔試劑本身又分為生物奈米孔試劑和固相奈米孔試劑。模板建構流程包括橋接PCR和乳液PCR兩種方法，每種方法對通量和應用領域的影響各不相同。

區域戰略觀點與美洲、歐洲、中東、非洲和亞太市場不同的監管、基礎設施和採購現實相一致。

區域趨勢影響著三大主要地區定序盒的需求模式、法規要求和供應鏈結構。在美洲，強大的學術網路和成熟的臨床診斷市場推動了對優先考慮合規性、可重複性和與現有儀器基礎設施整合的試劑盒的需求。採購流程受到機構採購週期和關鍵試劑國內生產能力的影響，因此，及時的技術支援和檢驗的通訊協定成為決定性採購標準。

透過產品組合整合、供應鏈彈性和端到端解決方案交付來決定成功的關鍵競爭對手和企業策略。

定序盒產業的企業策略日益取決於其產品組合的廣度、技術支援水準以及提供整合工作流程的能力，從而降低應用門檻。主要企業優先考慮與多種定序平台的兼容性，同時投資於配方改進，以延長保存期限並簡化通訊協定流程。與儀器製造商、自動化供應商和生物資訊解決方案供應商建立策略合作夥伴關係，透過建構滿足濕實驗室和數據驅動型需求的端到端解決方案，進一步提升了價值提案。

為製造商和供應商提供切實可行的策略建議，以增強韌性、擴大部署範圍，並將定序盒快速整合到複雜的實驗室工作流程中。

產業領導企業可以採取實際措施來鞏固其市場地位，並應對技術和政策主導的變化。首先，優先考慮供應鏈多元化，並為關鍵試劑和耗材建立雙重採購安排，可降低貿易中斷的風險。其次，投資區域製造可縮短前置作業時間，提高服務應對力。第三，投資模組化試劑盒架構和自動化平台的標準化介面，可以擴大目標客戶群，並降低高通量實驗室的整合門檻。

結合與主要相關人員的對話、技術檢驗和供應鏈分析，採用穩健、全面的調查方法，為決策者提供可操作且可靠的見解。

本研究整合了多層次調查方法所獲得的洞見，該方法結合了與關鍵相關人員的對話、嚴謹的二手資料研究和技術檢驗。主要研究包括對研究主管、採購負責人、產品經理和法規遵循專家進行深入訪談，以獲取關於營運重點、挑戰和推廣促進因素的第一手觀點。此外，還對技術文獻、法規指導文件和產品規格進行了全面審查，以準確反映試劑盒的化學特性、工作流程依賴性和合規性考量，從而補充了這些定性資訊。

結論明確了相關人員在應對定序試劑盒創新、監管和供應鏈的複雜性時應優先考慮的策略重點。

簡而言之，定序盒在實現高品質基因組和轉錄組分析中發揮著至關重要的作用，隨著其應用領域和平台的日益多元化，其策略重要性也與日俱增。能夠根據特定應用需求客製化產品設計、投資供應鏈韌性並提供與自動化和數據工作流程檢驗整合的製造商和經銷商，將更有能力滿足科學研究和臨床領域客戶不斷變化的需求。政策和貿易情勢的變化凸顯了靈活籌資策略和透明溝通對於降低中斷風險的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 NGS試劑盒市場：依產品類型分類

  • 樣品製備工具包
    • DNA樣品製備盒
    • RNA樣品製備盒
  • 定序盒
  • 模板製備工具包

第9章：依定序技術分類的NGS試劑盒市場

  • 奈米孔定序
    • 生物奈米孔
    • 固態奈米孔
  • 連接定序
  • 合成定定序
  • 離子半導體定序

第10章檢體類型分類的NGS試劑盒市場

  • 血
  • 組織
  • 唾液
  • 微生物樣本

第11章 NGS試劑盒市場：依應用領域分類

  • EXOME定序
    • 臨床EXOME定序
    • EXOME定序研究
  • 目標序列
    • 基於雜合反應法的標靶定序
    • 基於PCR的標靶定序
  • 轉錄組序列
    • 批量RNA定序
    • 單細胞RNA定序
  • 全基因組定序

第12章 NGS試劑盒市場：依最終用戶分類

  • 學術研究機構
  • 臨床實驗室
  • 製藥和生物技術公司

第13章 NGS試劑盒市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 NGS試劑盒市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 NGS試劑盒市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國NGS試劑盒市場

第17章：中國NGS試劑盒市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Creative Biogene
  • Danaher Corporation
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Illumina, Inc.
  • Invivoscribe, Inc.
  • LGC Biosearch Technologies
  • New England Biolabs
  • Oxford Nanopore Technologies plc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN NV
  • seqWell
  • Takara Bio Inc.
  • Tecan Trading AG
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corporation
Product Code: MRR-5C6F41F5AFEA

The NGS Kits Market was valued at USD 2.82 billion in 2025 and is projected to grow to USD 3.17 billion in 2026, with a CAGR of 13.03%, reaching USD 6.65 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.82 billion
Estimated Year [2026] USD 3.17 billion
Forecast Year [2032] USD 6.65 billion
CAGR (%) 13.03%

An authoritative introduction to the evolving role of sequencing kits in enabling robust genomic and transcriptomic workflows across research and clinical environments

Next-generation sequencing kits are foundational tools that enable high-resolution genomic, transcriptomic and epigenomic analysis across research, clinical and industrial settings. These kits encompass reagents, consumables and preparative workflows that convert biological samples into sequencing-ready libraries and templates, and their performance characteristics materially influence downstream data quality and interpretability. As sequencing applications diversify, kit design has evolved to prioritize flexibility, throughput compatibility and minimized hands-on time, supporting a broader range of experimental designs from targeted panels to whole genome interrogation.

Across contemporary laboratory ecosystems, kit providers face escalating expectations for reproducibility, regulatory readiness and integration with automated platforms. Consequently, innovation has concentrated on reducing protocol complexity, improving reagent stability and enabling compatibility with multiple instrument architectures. At the same time, end users demand transparent documentation and robust technical support to reduce adoption friction. This introduction situates sequencing kits within the broader lifecycle of genomic assays, emphasizing how incremental improvements in kit chemistry and workflow ergonomics cumulatively shape experimental outcomes, influence purchasing decisions and inform strategic partnerships across the life sciences value chain.

How converging innovations in chemistry, automation and platform compatibility are redefining sequencing kits and reshaping laboratory workflows across genomics

The landscape for sequencing kits is undergoing transformative shifts driven by concurrent advances in chemistry, nanopore and synthesis-based readout technologies, and the maturation of single-cell and long-read applications. Historically, sequencing workflows emphasized incremental gains in read accuracy and throughput, but recent progress has pivoted attention toward versatility and end-to-end workflow optimization. For example, library preparation has become more modular, enabling labs to tailor input requirements and enrichment strategies without extensive protocol redevelopment. In parallel, improvements in template preparation and PCR-based amplification approaches have enhanced uniformity and reduced bias, particularly for complex genomes and low-input samples.

Moreover, sequencing platform evolution is prompting kit manufacturers to reimagine reagent sets and compatibility matrices. Emergent nanopore chemistries and enhanced sequencing-by-synthesis formulations require bespoke library and sequencing kits that reconcile instrument-specific constraints with user expectations for ease of use. This technological plurality encourages kit developers to adopt platform-agnostic designs or to invest in tight integration with specific instrument ecosystems. At the same time, digital innovations in sample tracking, barcoding and integration with bioinformatics pipelines are transforming what users expect from a kit beyond wet-lab performance, creating a competitive landscape where reagent quality, software interoperability and end-user experience converge.

Assessing the operational and supply chain consequences of recent tariff shifts and their implications for procurement resilience and supplier strategies in sequencing kits

Trade policy shifts, including tariff adjustments, exert a tangible influence on the procurement and distribution dynamics for sequencing kits, particularly for organizations that source reagents, consumables and instrument-compatible accessories across borders. Tariffs alter landed costs and create incentives for firms to reassess supplier portfolios, adopt alternative logistics strategies, or localize certain manufacturing activities to maintain reliable supply and predictable pricing. As a result, procurement teams and commercial leaders are re-evaluating supplier contracts and exploring contractual mechanisms to mitigate exposure to abrupt cost escalations, while regulatory and customs compliance functions are intensifying documentation practices to avoid shipment delays.

In response to new tariff regimes, manufacturers may prioritize regional manufacturing investments or adjust their distribution footprints to preserve service levels for clinical and research customers. These strategic adjustments can lead to modified lead times, revised minimum order requirements and changes in how after-sales support is structured across territories. Importantly, tariff-driven cost pressures also affect the entire value chain, creating incentives for stakeholders to streamline kit formulations, reduce packaging complexity and optimize palletization to lower transportation inefficiencies. These operational adaptations underscore the need for coordinated supply chain resilience planning and the importance of establishing transparent communication channels with end users to manage expectations during periods of trade policy volatility.

Comprehensive segmentation insights that map product types, application demands, end-user profiles and sequencing technologies to strategic kit design and deployment

Detailed segmentation provides clarity on the distinct product configurations and user requirements that define the sequencing kits ecosystem. Product type distinctions separate library preparation kits, sequencing kits and template preparation kits, with library preparation further differentiating amplicon-focused kits, RNA sequencing optimized kits and whole genome library solutions. Sequencing kit varieties include nanopore-oriented chemistries alongside sequencing-by-synthesis formulations, and the nanopore category itself splits into biological nanopore reagents and solid-state implementations. Template preparation workflows capture both bridge PCR and emulsion PCR approaches, each with implications for throughput and application suitability.

Application-based segmentation frames how kits are tailored to specific analytical goals, ranging from exome and targeted sequencing use cases to transcriptome analyses and whole genome interrogation. Exome protocols vary between clinical-grade and research-focused implementations, while targeted strategies encompass hybridization-based enrichment as well as PCR-driven target selection. Transcriptome sequencing includes both bulk RNA and single-cell RNA methodologies, each driving distinct requirements for input handling and amplification fidelity. End-user segmentation emphasizes the different operational demands of academic research institutes, clinical diagnostic laboratories and pharmaceutical or biotechnology companies, and highlights nuance within these categories such as government research centers versus university laboratories, hospital diagnostic facilities versus independent labs, and the distinctions between startup biotechnology firms and established global pharmaceutical companies. Finally, sequencing technology segmentation differentiates core platforms including nanopore, sequencing by ligation and sequencing by synthesis, with further granularity between biological and solid-state nanopore implementations, which influence kit chemistry choices and workflow integration strategies.

Taken together, these segmentation lenses clarify how product design, regulatory readiness and service models must be aligned to the specific needs of applications and end users, enabling manufacturers and distributors to prioritize product roadmaps and technical support offerings that resonate with their target customer segments.

Regional strategic perspectives that reconcile distinct regulatory, infrastructure and procurement realities across Americas, Europe Middle East and Africa and Asia Pacific markets

Regional dynamics shape demand patterns, regulatory requirements and supply chain architectures for sequencing kits across three primary geographies. In the Americas, robust academic networks and a mature clinical diagnostics market drive demand for kits that emphasize regulatory compliance, reproducibility and integration with established instrument bases. Procurement processes are influenced by institutional purchasing cycles and the presence of domestic manufacturing capacity for key reagents, creating a context in which timely technical support and validated protocols are decisive purchasing criteria.

Across Europe, Middle East & Africa, diverse regulatory landscapes and heterogeneous research infrastructures create both challenges and opportunities for kit providers. Harmonization efforts and pan-regional clinical networks increase the appeal of kits with strong documentation, multilingual technical resources and adaptable workflows that can be validated locally. Additionally, emerging biotech hubs in several markets within this region are accelerating adoption of advanced sequencing approaches, prompting suppliers to offer flexible supply arrangements and localized training programs.

In the Asia-Pacific region, rapid expansion of genomic research capabilities and increasing clinical sequencing penetration favor kits that can scale across high-volume operations while remaining cost-effective and robust in varied laboratory settings. Local manufacturing initiatives and government-supported research programs further incentivize suppliers to establish regional presences, co-development partnerships and localized quality systems to meet regulatory expectations and expedite market entry. Collectively, regional considerations underscore the need for geographically informed product strategies and supply chain models that accommodate differing regulatory, infrastructural and commercial realities.

Key competitive dynamics and corporate strategies that determine success through portfolio integration, supply chain resilience and end to end solution offerings

Company strategies within the sequencing kits arena are increasingly defined by portfolio breadth, depth of technical support and the ability to offer integrated workflows that reduce barriers to adoption. Leading kit developers emphasize compatibility with multiple sequencing platforms while investing in formulation improvements that enhance shelf life and reduce protocol complexity. Strategic partnerships with instrument manufacturers, automation vendors and bioinformatics solution providers further extend value propositions by creating end-to-end solutions that address both wet-lab and data-driven needs.

In addition to product innovation, competitive differentiation arises from supply chain reliability and the capacity to deliver validated protocols and training at scale. Companies that maintain transparent quality systems, responsive technical service and clear documentation gain traction among diagnostics laboratories and large research consortia that prioritize reproducibility and regulatory readiness. Moreover, where companies pursue vertical integration-combining reagent production with consumable manufacturing and distribution-they can offer bundled solutions that simplify procurement and support lifecycle management. Finally, an emphasis on modular kit design and application-specific optimization enables firms to capture diverse use cases while minimizing the need for extensive inventory SKUs, supporting both operational efficiency and customer-focused customization.

Actionable strategic recommendations for manufacturers and providers to enhance resilience, broaden adoption and accelerate integration of sequencing kits into complex laboratory workflows

Industry leaders can take concrete actions to strengthen market position and respond to both technological and policy-driven shifts. First, prioritizing supply chain diversification and establishing dual-sourcing arrangements for critical reagents and consumables will reduce vulnerability to trade disruptions, while regional manufacturing investments can shorten lead times and enhance service responsiveness. Second, investing in modular kit architectures and standardized interfaces for automation platforms will broaden addressable customer segments and lower barriers to integration for high-throughput laboratories.

Third, engaging proactively with regulatory bodies and clinical stakeholders to develop validated, documentation-rich kit offerings will accelerate adoption in diagnostic settings and build trust among procurement decision-makers. Fourth, deepening collaboration with instrument and software partners to deliver verified end-to-end workflows will create compelling value propositions that go beyond single-product sales. Finally, cultivating robust post-sale support, including hands-on training, protocol optimization services and rapid technical escalation pathways, will increase customer retention and enable manufacturers to capture customer-driven product improvements through feedback loops that inform iterative innovation.

A robust mixed methodology combining primary stakeholder engagement, technical validation and supply chain analysis to produce practical and reliable insights for decision makers

This research synthesizes insights from a layered methodology that combines primary stakeholder engagement with rigorous secondary analysis and technical validation. Primary research included in-depth interviews with laboratory directors, procurement specialists, product managers and regulatory affairs professionals to capture first-hand perspectives on operational priorities, pain points and adoption drivers. These qualitative inputs were complemented by a comprehensive review of technical literature, regulatory guidance documents and product specification sheets to ensure accurate representation of kit chemistries, workflow dependencies and compliance considerations.

To augment qualitative findings, the analysis incorporated product portfolio mapping, patent landscape assessment and supply chain tracing to identify common manufacturing dependencies and distribution models. Technical validation was achieved through cross-referencing vendor protocol performance claims with independent experimental reports and user feedback, while expert panel reviews provided additional scrutiny of categorizations and strategic implications. Throughout the methodology, emphasis was placed on triangulation and transparency to ensure that conclusions reflect convergent evidence rather than single-source assertions, enabling practical recommendations that are grounded in operational realities.

Concluding perspectives that crystallize the strategic priorities for stakeholders to navigate innovation, regulation and supply chain complexity in sequencing kits

In sum, sequencing kits occupy a pivotal role in enabling high-quality genomic and transcriptomic assays, and their strategic importance is increasing as applications diversify and platform plurality expands. Manufacturers and distributors who align product design with application-specific needs, invest in supply chain resilience, and offer verifiable integration with automation and data workflows will be best positioned to meet the evolving expectations of research and clinical customers. Policy and trade developments underscore the need for flexible sourcing strategies and transparent communication to mitigate disruption risks.

Looking ahead, the most successful organizations will balance rapid innovation in kit chemistries and workflows with a relentless focus on reproducibility, regulatory alignment and post-sale support. By doing so, they can not only address current operational constraints but also enable laboratories to adopt more ambitious experimental designs that drive scientific and clinical advances. This conclusion highlights the strategic imperatives that should guide R&D prioritization, commercial planning and customer engagement across the sequencing kits ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. NGS Kits Market, by Product Type

  • 8.1. Library Preparation Kits
    • 8.1.1. DNA Library Prep Kits
    • 8.1.2. RNA Library Prep Kits
  • 8.2. Sequencing Kits
  • 8.3. Template Preparation Kits

9. NGS Kits Market, by Sequencing Technology

  • 9.1. Nanopore Sequencing
    • 9.1.1. Biological Nanopore
    • 9.1.2. Solid-State Nanopore
  • 9.2. Sequencing By Ligation
  • 9.3. Sequencing By Synthesis
  • 9.4. Ion Semiconductor Sequencing

10. NGS Kits Market, by Sample Type

  • 10.1. Blood
  • 10.2. Tissue
  • 10.3. Saliva
  • 10.4. Microbial Samples

11. NGS Kits Market, by Application

  • 11.1. Exome Sequencing
    • 11.1.1. Clinical Exome Sequencing
    • 11.1.2. Research Exome Sequencing
  • 11.2. Targeted Sequencing
    • 11.2.1. Hybridization Based Targeted Sequencing
    • 11.2.2. PCR Based Targeted Sequencing
  • 11.3. Transcriptome Sequencing
    • 11.3.1. Bulk RNA Sequencing
    • 11.3.2. Single Cell RNA Sequencing
  • 11.4. Whole Genome Sequencing

12. NGS Kits Market, by End User

  • 12.1. Academic Research Institute
  • 12.2. Clinical Diagnostic Laboratories
  • 12.3. Pharmaceutical Biotechnology Companies

13. NGS Kits Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. NGS Kits Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. NGS Kits Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States NGS Kits Market

17. China NGS Kits Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. BGI Group
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. Creative Biogene
  • 18.9. Danaher Corporation
  • 18.10. Eurofins Scientific SE
  • 18.11. F. Hoffmann-La Roche Ltd
  • 18.12. Hologic, Inc.
  • 18.13. Illumina, Inc.
  • 18.14. Invivoscribe, Inc.
  • 18.15. LGC Biosearch Technologies
  • 18.16. New England Biolabs
  • 18.17. Oxford Nanopore Technologies plc.
  • 18.18. Pacific Biosciences of California, Inc.
  • 18.19. PerkinElmer Inc.
  • 18.20. Promega Corporation
  • 18.21. QIAGEN N.V.
  • 18.22. seqWell
  • 18.23. Takara Bio Inc.
  • 18.24. Tecan Trading AG
  • 18.25. Thermo Fisher Scientific, Inc.
  • 18.26. Twist Bioscience Corporation
  • 18.27. Zymo Research Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NGS KITS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NGS KITS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NGS KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NGS KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NGS KITS MARKET SIZE, BY DNA LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NGS KITS MARKET SIZE, BY DNA LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NGS KITS MARKET SIZE, BY DNA LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NGS KITS MARKET SIZE, BY RNA LIBRARY PREP KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NGS KITS MARKET SIZE, BY RNA LIBRARY PREP KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NGS KITS MARKET SIZE, BY RNA LIBRARY PREP KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NGS KITS MARKET SIZE, BY TEMPLATE PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NGS KITS MARKET SIZE, BY BIOLOGICAL NANOPORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NGS KITS MARKET SIZE, BY SOLID-STATE NANOPORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY LIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NGS KITS MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NGS KITS MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NGS KITS MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NGS KITS MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NGS KITS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NGS KITS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NGS KITS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NGS KITS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NGS KITS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NGS KITS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NGS KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NGS KITS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NGS KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NGS KITS MARKET SIZE, BY MICROBIAL SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NGS KITS MARKET SIZE, BY MICROBIAL SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NGS KITS MARKET SIZE, BY MICROBIAL SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NGS KITS MARKET SIZE, BY RESEARCH EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NGS KITS MARKET SIZE, BY HYBRIDIZATION BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NGS KITS MARKET SIZE, BY PCR BASED TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NGS KITS MARKET SIZE, BY BULK RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NGS KITS MARKET SIZE, BY SINGLE CELL RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NGS KITS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NGS KITS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NGS KITS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NGS KITS MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NGS KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS NGS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL NGS KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 202. GCC NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 205. GCC NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. G7 NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 235. G7 NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 238. G7 NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 246. NATO NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 249. NATO NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL NGS KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA NGS KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA NGS KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA NGS KITS MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA NGS KITS MARKET SIZE, BY SEQUENCING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA NGS KITS MARKET SIZE, BY NANOPORE SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA NGS KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA NGS KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA NGS KITS MARKET SIZE, BY EXOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA NGS KITS MARKET SIZE, BY TARGETED SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA NGS KITS MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA NGS KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)